Abstract
Pediculosis capitis is the most common ectoparasitic disease in children in industrialized countries and extremely common in resource-poor communities of the developing world. The extensive use of pediculicides with a neurotoxic mode of action has led to the development and spread of resistant head lice populations all over the world. This triggered the development of compounds with other modes of action. The current literature on treatment approaches of head lice infestation was searched, and published randomized controlled trials were critically analyzed. The following compounds/family of compounds were identified: spinosad, a novel compound with a new neurotoxic mode of action, isopropyl myristate, 1,2-octanediol, ivermectin, plant-based products, and dimeticones. The efficacy and safety of these compounds are reviewed and recommendations for the treatment of pediculosis capitis in individuals as well as the interruption of ongoing epidemics are provided.
Similar content being viewed by others
References
Jahnke C, Bauer E, Feldmeier H. Pediculosis capitis im Kindesalter: epidemiologische und sozialmedizinische Erkenntnisse einer Reihenuntersuchung von Schulanfängern. Gesundheitswesen. 2008;70(11):667–73.
Rukke BA, Birkemoe T, Soleng A, Heggen-Lindstedt H, Ottesen P. Head lice prevalence among households in Norway; importance of spatial variables and individual and household characteristics. Parasitology. 2011;138:1296–304.
Feldmeier H, Heukelbach J. Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues. Bull World Health Org. 2009;87(2):152–9.
Feldmeier H. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment. Eur J Clin Microbiol Infect Dis. 2012;31:2105–10.
Lesshafft H, Baier A, Guerra H, Terashima A, Feldmeier H. Prevalence and risk factors associated with pediculosis capitis in an impoverished urban community in Lima, Peru. J Global Infect Dis. 2013;5(4):138–42.
Falagas ME, Matthaiou DK, Rafailidis PI, Panos G, Pappas G. Worldwide prevalence of head lice. Emerg Infect Dis. 2008;14(9):1493–4.
Vassena CV, MougabureCueto GA, Alzogaray RA, Zerba EN, Picollo MI. Prevalence and levels of permethrin resistance in Pediculus humanus capitis De Geer (Anoplura: Pediculidae) from Buenos Aires, Argentina. J Med Entomol. 2003;40:447–50.
Kasai S, Ishii N, Natsuaki M, Fukutomi H, Komagata O, Kobayashi M, Tomita T. Prevalence of kdr-like mutations associated with pyrethroid resistance in human head louse populations in Japan. J Med Entomol. 2009;46(1):77–82.
Durand R, Millard B, Bouges-Michel C, Bruel C, Bouvresse S, Izri A. Detection of pyrethroid resistance gene in head lice in schoolchildren from Bobigny, France. J Med Entomol. 2007;44:796–7.
Kristensen M, Knorr M, Rasmussen AM, Jespersen JB. Survey of permethrin and malathion resistance in human head lice populations from Denmark. J Med Entomol. 2006;43:533–8.
Yoon KS, Gao JR, Lee SH, Clark JM, Brown L, Taplin D. Permethrin resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol. 2003;139:994–1000.
Barker SC, Burgess IF, Terri L, Meinking TL, Mumcuoglu KY. International guidelines for clinical trials with pediculocides. Int J Dermatol. 2012;51:853–8.
Feldmeier H, Jahnke C. Pediculosis capitis: epidemiologie, diagnose und therapie. Pädiatrische Praxis. 2010;76:359–70.
Jahnke C, Bauer E, Hengge U, Feldmeier H. Accuracy of diagnosis of pediculosis capitis: visual inspection versus wet combing. Arch Dermatol. 2009;145:309–13.
Pickett MM, Muszynski MA, Norton S. Of Lice and Men. JAMA Dermatol. 2014;150(3):250.
Veracx A, Raoult D. Biology and genetics of human head and body lice. Trends Parasitol. 2012;28:563–71.
Parola P, Fournier PE, Raoult D. Bartonella quintana, lice, and molecular tools. J Med Entomol. 2006;43:787.
Light JE, Allen JM, Long LM, Carter TE, Barrow L, Suren G, Raoult D, Reed DL. Geographic distributions and origins of human head lice (Pediculus humanus captitis) based on mitochondrial data. J Parasitol. 2008;94(6):1275–81.
Boutellis A, Medlannikov O, Bilcha KD, Ali J, Campelo D, Barker SC, Raoult D. Borrelia recurrentis in head lice, Ethiopia. Emerg Infect Dis. 2013;19:796–8.
Angelakis E, Diatta G, Abdissa A, Trape JF, Mediannikov O, Richet H, Raoult D. Altitude-dependent Bartonella quintana genotype C in head lice, Ethiopia. Emerg Infect Dis. 2011;17(12):2357–9.
Feldmeier H. Lice as vectors of pathogenic microorganisms. In: Heukelbach J, editor. Management and control of head lice infestation. Bremen: UNIMED; 2010. p. 132–5.
Do-Pham G, Le Cleach L, Giraudeau B, Maruani A, Chosidow O, Ravaud P. Designing randomized-controlled trials to improve head louse treatment: systematic review using a vignette-based method. J Investig Dermatol. 2014;134:628–34.
Sonnberg S, Oliveira FA, de Melo ILA, de Melo Soares MM, Becher H, Heukelbach J. Ex vivo development of eggs from head lice (Pediculus humanus capitis). Open Dermatol J. 2010;4:82–9.
Strycharz JP, Lao AR, Alves A, Clark JM. Ovicidal respone of NYDA formulations on the human head louse (Anoplura: PEdiculidae) using a hair tuft bioassay. Lanham: Entomological Society of America; 2012.
Elston DM. Drug-resistant lice. Arch Dermatol. 2003;139:1061–4.
Picollo MI, Vassena CV, Mougabure Cueto GA, Vernetti M, Zerba E. Resistance to insecticides and effect of synergesis on permethrin toxicity in Pediculus capitis (Anoplura: Pediculidae) from Buenos Aires. J Med Entomol. 2000;37:721–5.
Bailey AM, Provic P. Persistent head lice following multiple treatments: evidence for insecticide resistance in Pediculus humanus capitis. Australas J Dermatol. 2000;41:250–4.
Hunter JA, Barker SC. Susceptibility of head lice (Pediculus humanus capitis) to pediculicides in Australia. Parasitol Res. 2003;90:476–8.
Burgess IF, Kay K, Burgess NA, Brunton ER. Soya oil-based shampoo superior to 0.5 % permethrin lotion for head louse infestation. Med Devices Evid Res. 2011;4(4):35–42.
Burgess IF, Lee PN, Brown CM. Randomised, controlled, parallel group clinical trials to evaluate the efficacy of isopropyl myristate/cyclomethicone solution against head lice. Pharm J. 2008;280:371–5.
Burgess IF, Brunton ER, Burgess NA. Clinical trial showing superiority of a coconut and anise spray over permethrin 0.43 % lotion for head louse infestation, ISRCTN96469780. Eur J Pediatr. 2010;169:55–62.
Burgess IF, Brunton ER, Burgess NA. Single application of 4 % dimeticone liquid gel versus two applications of 1 % permethrin creme rinse for treatment of head louse infestation: a randomised controlled trial. BMC Dermatol. 2013;13:5. doi:10.1186/1471-5945-13-5.
van der Stichele RHV, Dezeure EM, Bogaert MG. Systematic review of clinical efficacy of topical treatments for head lice. BMJ. 1998;311:604–8.
Burgess IF, Brown CM, Lee PN. Treatment of head louse infestation with 4 % dimeticone lotion: randomised controlled equivalence trial. BMJ. 2005;330:1423–6.
Plastow L, Luthra M, Powell R, Wright J, Russel D, Marshall MN. Head lice infestation: bug busting vs. traditional treatment. J Clin Nurs. 2001;10:775–83.
Willems S, Lapeere H, Haedens N, Pasteels I, Naeyaert JM, De Maeseneer J. The importance of socio-economic status and individual characteristics on the prevalence of head lice in schoolchildren. Eur J Dermatol. 2005;15(5):387–92.
Tomalik-Scharte D, Lazar A, Meins J, Bastian B, Ihrig M, Wachall B, Jetter A, Tantcheva-Poor I, Mahrle G, Fuhr U. Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol. 2005;61(5–6):399–404.
Anonymous Topische Therapie bei Kopfläusen. Der Arzneimittelbrief. 2009;43:81–86.
Menegaux F, Baruchel A, Bertrand Y, Lescoeur B, Leverger G, Nelken B, Sommelet D, Hémon D, Clavel C. Household exposure to pesticides and risk of childhood leukaemia. Occup Environ Med. 2006;63(2):131–4.
Stough D, Shellabarger S, Quiring J, Gabrielsen AA Jr. Efficacy and safety of spinosad and permethrin creme rinses for Pediculosis capitis (head lice). Pediatrics. 2009;124(3):389–95.
Heukelbach J, Canyon DV, Heukelbach-Oliveira F, Muller R, Spear RC. In vitro efficacy of over-the-counter botanical pediculicides against the head louse Pediculus humanus var capitis based on a stringent standard for mortality assessment. Med Vet Entomol. 2008;22:262–74.
Heukelbach J, Canyon DV, Speare R. The effect of natural products on head lice: in vitro tests and clinical evidence. J Pediatr Infect Dis. 2007;2:67–76.
Strycharz JP, Yoon KS, Clark JM. A new ivermectin formulation topically kills permethrin-resistant human head lice (Anoplura: Pediculidae). J Med Entomol. 2008;45(1):75–81.
Barnett E, Palma KG, Clayton B, Ballard T. Effectiveness of isopropyl myristate cylcomethicone of removing cuticular hydrocarbons from human head lice. BMC Dermatol. 2012;12:15. doi:10.1186/1471-5945-12-15.
Kaul N, Palma KG, Silagy SS, Goodman JJ, Toole J. North American efficacy and safety of a novel pediculicide rinse, isopropyl myristate 50 % (Resultz). J Cutan Med Surg. 2007;11(5):161–7.
Burgess IF, Lee PN, Kay K, Jones R, Brunton ER. 1,2-Octanediol, a novel surfactant, for treating headlouse infestation: identification of activity, formulation, and randomised, controlled trials. PLoS One. 2012;7(4):e35419.
Burgess IF, Brunton ER, French R, Burgess NA. Prevention of head louse infestation: a randomised, double-blind, cross-over study of a novel concept product, 1 % 1,2-octanediol spray versus placebo. BMJ Open. 2014;4(5):e004634.
Feldmeier H. Pediculosis capitis: Eine Herausforderung für das Apothekerteam. PTA-Forum. 2013;11:22–6.
Heukelbach J, Oliveira FA, Richter J, Häussinger D. Dimeticone-based pediculicides: a physical approach to eradicate head lice. Open Dermatol J. 2010;4:77–81.
Burgess IF. The mode of action of dimeticone 4 % lotion against head lice, Pediculus capitis. BMC Pharmacol. 2009;9:3. doi:10.1186/1471-2210-9-3.
Richling I, Böckeler W. Lethal effects of treatment with a special dimeticone formula on head lice and house crickets (Orthoptera, Ensifera: Acheta domestica and Anoplura, Phthiraptera: Pediculus humanus). Arzneim-Forsch/Drug Res. 2008;58:248–54.
Heukelbach J, Pilger D, Oliveira F, Khakban A, Ariza L, Feldmeier H. A highly efficacious pediculocide based on dimeticone: randomized observer blinded comparative trial. BMC Infect Dis. 2008;8:115. doi:10.1186/1471-2334-8-115.
Heukelbach J, Sonnberg S, Becher H, Melo I, Speare R, Oliveira FA. Ovicidal efficacy of high concentration dimeticone: a new era of head lice treatment. J Am Acad Dermatol. 2011;64(4):e61–2.
Nair B. Final report on the safety assessment of stearoxy dimethicone, dimethicone, methicone, amino bispropyl dimethicone, aminopropyl dimethicone, amodimethicone, amodimethicone hydroxystearate, behenoxy dimethicone, C24-28 alkyl methicone, C30-45 alkyl methicone, C30-45 alkyl dimethicone, cetearyl methicone, cetyl dimethicone, dimethoxysilyl ethylenediaminopropyl dimethicone, hexyl methicone, hydroxypropyldimethicone, stearamidopropyl dimethicone, stearyl dimethicone, stearyl methicone, and vinyldimethicone. Int J Toxicol. 2003;22:11–35.
Lapeere H, Brochez L, Verhaeghe E, Vander-Stichele RH, Remon JP, Lambert J, Leybaert L. Efficacy of products to remove eggs of Pediculosis humanus capitis (Phthiraptera: Pediculidae) from the human hair. J Med Entomol. 2014;51(2):400–7.
Meinking TL, Mertz-Rivera K, Villar ME, Bell M. Assessment of the safety and efficacy of three concentrations of topical ivermectin lotion as a treatment for head lice infestation. Int J Dermatol. 2013;52:106–12.
Dornseiff M, Schwartz T. Randomisierte, Untersucher-verblindete kontrollierte, multizentrische Therapiestudie mit Dodecanol plus Demeticon (Dimet® 20*) versus Dimeticon-Mono bei Kopflausbefall—Integrierter Abschlussbericht. 2010. http://www.infectopharm.com/login?ref=/egi-bin/dl.pl/downloads/dimet20studie_2010.pdf. Assessed 21 July 2014.
Deeks LS, Naunton M, Currie MJ, Bowden FJ. Topical ivermectin 0.5 % lotion for treatment of head lice. Ann Pharmacother. 2013;47(9):1161–7.
Burgess I. Head lice. Clin Evid (Online). 2011;05:pii:1703.
Laguna MF, Risau-Gusman S. Of lice and math: using models to understand and control populations of head lice. Plos One. 2011;6(7):e21848. doi:10.1371/journal.pone.0021848.
Greive KA, Lui AH, Barnes TM, Oppenheim VM. Safety and efficacy of a non-pesticide-based head lice treatment: results of a randomised comparative trial in children. Australas J Dermatol. 2012;53(4):255–63.
Mumcuoglu KY, Miller J, Zamir C, Zentner G, Helbin V, Ingber A. The in vivo pediculicidal efficacy of a natural remedy. IMAJ. 2002;4(10):790–2.
Barker SC, Altman PM. A randomised, assessor blind, parallel group comparative efficacy trial of three products for the treatment of head lice in children-melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a “suffocation” product. BMC Dermatol. 2010;10:6. doi:10.1186/1471-5945-10-6.
Chosidow O, Giraudeau G, Cottrell J, Izri A, Hofmann R, Mann SG, Burgess IF. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med. 2010;362(10):896–905.
Pariser DM, Meinking TL, Bell M, Ryan WG. Topical 0.5 % ivermectin lotion for treatment of head lice. N Engl J Med. 2012;367(18):1687–93.
Nofal A. Orales ivermectin gegen Kopfläuse: ein Vergleich mi 0,5 % topischer Malathionlotion. JDDG. 2010;8(12):985–9.
Pilger D, Heukelbach J, Khakban A, de Oliveiera FAS, Fengler G, Feldmeier H. Household-wide ivermectin treatment for head lice in an impoverished community: randomized observer-blinded controlled trial. Bull World Health Org. 2010;88:90–6. doi:10.2471/BLT.08.051656):90-96.
Burgess IF, Lee PN, Matlock G. Randomised, controlled, assessor blind trial comparing 4 % dimeticone lotion with 0.5 % malathion liquid for head lice infestation. PLoS One. 2007;11:e1127.
Kurt O, Balcioglu C, Burgess IF, Limoncu ME, Girginkardesler N, Tabak T, Muslu H, Ermis O, Sahin MT, Bilac C, Kavur H, Ozbel Y. Treatment of head lice with dimeticone 4 % lotion: comparison of two formulations in a randomised controlled trial in rural Turkey. BMC Public Health. 2009;9:441.
Acknowledgments
The excellent secretarial assistance by U. Kolander is gratefully acknowledged.
Conflict of interest
Dr. Feldmeier reports receiving consulting and lecture fees from Pohl-Boskamp. No other potential conflict of interest relevant to this article is reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feldmeier, H. Treatment of Pediculosis Capitis: A Critical Appraisal of the Current Literature. Am J Clin Dermatol 15, 401–412 (2014). https://doi.org/10.1007/s40257-014-0094-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-014-0094-4